Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
PTCT
|
Eric Pauwels
CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct | 431 Reduced 1.16% |
$26,744
$62.05 p/Share
|
Jan 25
2021 |
PTCT
|
Stuart Walter Peltz
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect | 350 Reduced 2.23% |
$21,717
$62.05 p/Share
|
Jan 25
2021 |
CVET
|
Benjamin Wolin
President and CEO |
SELL
Open market or private sale
|
Direct | 2,778 Reduced 3.68% |
$106,370
$38.29 p/Share
|
Jan 25
2021 |
DIOD
|
Shew Lu Keh |
SELL
Open market or private sale
|
Indirect | 300 Reduced 0.02% |
$24,126
$80.42 p/Share
|
Jan 25
2021 |
PGNY
|
Jennifer Bealer
EVP, GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct | 2,310 Reduced 3.4% |
$115,015
$49.79 p/Share
|
Jan 25
2021 |
INSM
|
Christine A Pellizzari
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 21,000 Reduced 12.99% |
$911,400
$43.4 p/Share
|
Jan 25
2021 |
PSMT
|
William J Naylon
EVP & Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 2,200 Reduced 6.12% |
$211,750
$96.25 p/Share
|
Jan 25
2021 |
CCXI
|
Markus J. Cappel
Chief Bus. Officer & Treasurer |
SELL
Open market or private sale
|
Direct | 1,375 Reduced 1.58% |
$92,166
$67.03 p/Share
|
Jan 25
2021 |
CCXI
|
Pui San Kwan
Principal Acctg Officer |
SELL
Open market or private sale
|
Direct | 4,184 Reduced 56.42% |
$271,960
$65.0 p/Share
|
Jan 25
2021 |
LNN
|
Michael Christodolou |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 6.85% |
$148,830
$148.83 p/Share
|
Jan 25
2021 |
LGND
|
John L Higgins
Director |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 17.52% |
$7,950,000
$159.0 p/Share
|
Jan 25
2021 |
FSLY
|
Paul Luongo
General Counsel |
SELL
Open market or private sale
|
Direct | 2,083 Reduced 0.82% |
$221,964
$106.56 p/Share
|
Jan 25
2021 |
XPEL
|
Richard K. Crumly
Director |
SELL
Open market or private sale
|
Indirect | 8,500 Reduced 0.41% |
$429,845
$50.57 p/Share
|
Jan 25
2021 |
ADPT
|
Chad M Cohen
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 98.04% |
$3,318,500
$66.37 p/Share
|
Jan 25
2021 |
ADPT
|
Julie Rubinstein
President and COO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 100.0% |
$996,900
$66.46 p/Share
|
Jan 25
2021 |
RGNX
|
Kenneth T. Mills |
SELL
Open market or private sale
|
Direct | 6,500 Reduced 2.26% |
$285,285
$43.89 p/Share
|
Jan 25
2021 |
LZB
|
Darrell Dewain Edwards
Senior Vice President and COO |
SELL
Open market or private sale
|
Direct | 17,365 Reduced 25.42% |
$781,425
$45.0 p/Share
|
Jan 25
2021 |
IRBT
|
Michelle Stacy |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 9.55% |
$218,000
$109.0 p/Share
|
Jan 25
2021 |
IRBT
|
Michelle Stacy |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 29.88% |
$248,000
$124.0 p/Share
|
Jan 25
2021 |
PACB
|
Michael Hunkapiller
Director |
SELL
Open market or private sale
|
Direct | 125,406 Reduced 12.88% |
$4,581,081
$36.53 p/Share
|
Jan 25
2021 |
ANF
|
Kristin A. Scott
President-Global Brands |
SELL
Open market or private sale
|
Direct | 152,509 Reduced 100.0% |
$3,812,725
$25.0 p/Share
|
Jan 25
2021 |
ALEC
|
Robert Paul
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 12.31% |
$540,300
$18.01 p/Share
|
Jan 25
2021 |
MORF
|
Omega Fund V, L.P.
Director |
SELL
Open market or private sale
|
Direct | 6,623 Reduced 0.24% |
$206,505
$31.18 p/Share
|
Jan 25
2021 |
BLNK
|
Donald Engel |
SELL
Open market or private sale
|
Direct | 60,000 Reduced 15.39% |
$2,691,600
$44.86 p/Share
|
Jan 25
2021 |
CHRS
|
Jean Frederic Viret
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 46,144 Reduced 42.95% |
$902,115
$19.55 p/Share
|
Jan 25
2021 |
CSTL
|
Daniel Bradbury
Director |
SELL
Open market or private sale
|
Indirect | 7,500 Reduced 0.32% |
$584,025
$77.87 p/Share
|
Jan 25
2021 |
RMNI
|
Daniel B. Winslow
EVP, CLO & Corp. Sec. |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 34.06% |
$73,100
$7.31 p/Share
|
Jan 25
2021 |
SLQT
|
William Thomas Grant Iii
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Indirect | 28,861 Reduced 1.59% |
$725,277
$25.13 p/Share
|
Jan 25
2021 |
SLQT
|
William Thomas Grant Iii
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 21,664 Reduced 1.36% |
$544,416
$25.13 p/Share
|
Jan 25
2021 |
SLQT
|
W Thomas Grant Ii
Director |
SELL
Open market or private sale
|
Indirect | 21,639 Reduced 1.4% |
$543,788
$25.13 p/Share
|
Jan 25
2021 |
SLQT
|
W Thomas Grant Ii
Director |
SELL
Open market or private sale
|
Direct | 21,576 Reduced 0.74% |
$541,989
$25.12 p/Share
|
Jan 25
2021 |
SLQT
|
Robert Clay Grant
PRESIDENT |
SELL
Open market or private sale
|
Indirect | 23,225 Reduced 1.38% |
$583,644
$25.13 p/Share
|
Jan 25
2021 |
SLQT
|
Robert Clay Grant
PRESIDENT |
SELL
Open market or private sale
|
Direct | 21,598 Reduced 1.74% |
$542,542
$25.12 p/Share
|
Jan 25
2021 |
SLQT
|
Raffaele Sadun
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 21,677 Reduced 2.16% |
$544,743
$25.13 p/Share
|
Jan 25
2021 |
SLQT
|
Timothy Robert Danker
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 21,642 Reduced 1.28% |
$543,647
$25.12 p/Share
|
Jan 25
2021 |
BTAI
|
Frank Yocca
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 14.51% |
$721,050
$48.07 p/Share
|
Jan 25
2021 |
EVER
|
John Brandon Wagner
CFO and Treasurer |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 1.93% |
$165,800
$41.45 p/Share
|
Jan 25
2021 |
LMNR
|
Mark Palamountain
SVP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct | 650 Reduced 1.02% |
$11,057
$17.01 p/Share
|
Jan 25
2021 |
LMNR
|
Harold S Edwards
President and CEO |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 0.61% |
$17,010
$17.01 p/Share
|
Jan 25
2021 |
GOCO
|
Shane E. Cruz
Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 75,000 Reduced 100.0% |
$1,098,000
$14.64 p/Share
|
Jan 25
2021 |
SMLR
|
Douglas Murphy Chutorian
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 1,250 Reduced 100.0% |
$113,112
$90.49 p/Share
|
Jan 25
2021 |
EPZM
|
Robert B Bazemore
President & CEO |
SELL
Open market or private sale
|
Direct | 6,069 Reduced 2.39% |
$69,247
$11.41 p/Share
|
Jan 25
2021 |
EPZM
|
Matthew Ros
Officer |
SELL
Open market or private sale
|
Direct | 2,872 Reduced 4.88% |
$32,770
$11.41 p/Share
|
Jan 25
2021 |
EPZM
|
Victoria Vakiener
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 599 Reduced 2.1% |
$6,835
$11.41 p/Share
|
Jan 25
2021 |
EPZM
|
Shefali Agarwal |
SELL
Open market or private sale
|
Direct | 2,872 Reduced 3.65% |
$32,770
$11.41 p/Share
|
Jan 25
2021 |
VRA
|
P. Michael Miller |
SELL
Open market or private sale
|
Indirect | 71,503 Reduced 3.35% |
$609,206
$8.52 p/Share
|
Jan 25
2021 |
VRA
|
Patricia R. Miller |
SELL
Open market or private sale
|
Indirect | 71,503 Reduced 3.35% |
$609,206
$8.52 p/Share
|
Jan 25
2021 |
APRN
|
Matthew B Salzberg
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 13,700 Reduced 10.65% |
$137,822
$10.06 p/Share
|
Jan 25
2021 |
RDI
|
Margaret Cotter
Chairperson, EVP - RE Dev/NY |
SELL
Open market or private sale
|
Indirect | 4,000 Reduced 0.24% |
$29,680
$7.42 p/Share
|
Jan 25
2021 |
RDI
|
James J. Cotter Living Trust
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 0.24% |
$29,680
$7.42 p/Share
|
Jan 25
2021 |